Articles with public access mandates - José CourtyLearn more
Not available anywhere: 1
Aerosol-assisted synthesis of tailor-made hollow mesoporous silica microspheres for controlled release of antibacterial and anticancer agents
J Poostforooshan, S Belbekhouche, M Shaban, V Alphonse, D Habert, ...
ACS applied materials & interfaces 12 (6), 6885-6898, 2020
Mandates: German Research Foundation
Available somewhere: 26
Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery
S Kossatz, J Grandke, P Couleaud, A Latorre, A Aires, ...
Breast Cancer Research 17, 1-17, 2015
Mandates: Government of Spain
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment
A Nicolas-Boluda, J Vaquero, L Vimeux, T Guilbert, S Barrin, ...
Elife 10, e58688, 2021
Mandates: European Commission, Agence Nationale de la Recherche, Swiss Cancer League
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature
ME Gilles, F Maione, M Cossutta, G Carpentier, L Caruana, S Di Maria, ...
Cancer research 76 (24), 7181-7193, 2016
Mandates: Swiss National Science Foundation, European Commission, Government of Italy
The extracellular matrix in pancreatic cancer: description of a complex network and promising therapeutic options
B Ferrara, C Pignatelli, M Cossutta, A Citro, J Courty, L Piemonti
Cancers 13 (17), 4442, 2021
Mandates: AIRC Foundation for Cancer Research in Italy
Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice
D El Khoury, D Destouches, R Lengagne, B Krust, Y Hamma-Kourbali, ...
BMC cancer 10, 1-12, 2010
Mandates: National Institute of Health and Medical Research, France
Iron oxide nanoparticles as carriers for DOX and magnetic hyperthermia after intratumoral application into breast cancer in mice: impact and future perspectives
S Piehler, H Dähring, J Grandke, J Göring, P Couleaud, A Aires, ...
Nanomaterials 10 (6), 1016, 2020
Mandates: European Commission, Government of Spain
The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt
M Sanhaji, J Göring, P Couleaud, A Aires, AL Cortajarena, J Courty, ...
Nanomedicine: Nanotechnology, Biology and Medicine 20, 101983, 2019
Mandates: European Commission
Targeting nucleolin for better survival in diffuse large B-cell lymphoma
N Jain, H Zhu, T Khashab, Q Ye, B George, R Mathur, RK Singh, ...
Leukemia 32 (3), 663-674, 2018
Mandates: US National Institutes of Health
Nucleolin promotes heat shock–associated translation of VEGF-D to promote tumor lymphangiogenesis
F Morfoisse, F Tatin, F Hantelys, A Adoue, AC Helfer, S Cassant-Sourdy, ...
Cancer research 76 (15), 4394-4405, 2016
Mandates: Fondazione Telethon, Italy
Weibel-palade bodies orchestrate pericytes during angiogenesis
M Cossutta, M Darche, G Carpentier, C Houppe, M Ponzo, F Raineri, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 39 (9), 1843-1858, 2019
Mandates: Agence Nationale de la Recherche
Cell surface nucleolin as active bait for nanomedicine in cancer therapy: A promising option
B Ferrara, S Belbekhouche, D Habert, C Houppe, B Vallée, ...
Nanotechnology 32 (32), 322001, 2021
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
16-kDa fragment of pleiotrophin acts on endothelial and breast tumor cells and inhibits tumor development
A Duces, R Karaky, D Martel-Renoir, L Mir, Y Hamma-Kourbali, I Bieche, ...
Molecular cancer therapeutics 7 (9), 2817-2827, 2008
Mandates: National Institute of Health and Medical Research, France
Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer
D Destouches, M Sader, S Terry, C Marchand, P Maillé, P Soyeux, ...
Oncotarget 7 (43), 69397, 2016
Mandates: National Institute of Health and Medical Research, France, Swiss Cancer League
Fabrication of large pore mesoporous silica microspheres by salt-assisted spray-drying method for enhanced antibacterial activity and pancreatic cancer treatment
S Belbekhouche, J Poostforooshan, M Shaban, B Ferrara, V Alphonse, ...
International Journal of Pharmaceutics 590, 119930, 2020
Mandates: German Research Foundation, Agence Nationale de la Recherche
3-O-sulfated heparan sulfate interactors target synaptic adhesion molecules from neonatal mouse brain and inhibit neural activity and synaptogenesis in vitro
A Maïza, N Sidahmed-Adrar, PP Michel, G Carpentier, D Habert, C Dalle, ...
Scientific reports 10 (1), 19114, 2020
Mandates: European Commission
The nucleolin antagonist N6L inhibits LINE1 retrotransposon activity in non-small cell lung carcinoma cells
KS Ramos, S Moore, I Runge, MA Tavera-Garcia, I Cascone, J Courty, ...
Journal of Cancer 11 (3), 733, 2020
Mandates: Agence Nationale de la Recherche
Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide
C Dos Santos, C Blanc, R Elahouel, M Prescott, G Carpentier, A Ori, ...
Biochimie 107, 350-357, 2014
Mandates: European Commission
Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies
M Darche, M Cossutta, L Caruana, C Houppe, ME Gilles, D Habert, ...
The FASEB Journal 34 (4), 5851-5862, 2020
Mandates: Agence Nationale de la Recherche
Nucleolin therapeutic targeting decreases pancreatic cancer immunosuppression
M Ponzo, A Debesset, M Cossutta, M Chalabi-Dchar, C Houppe, C Pilon, ...
Cancers 14 (17), 4265, 2022
Mandates: European Commission, Agence Nationale de la Recherche, Swiss Cancer League …
Publication and funding information is determined automatically by a computer program